These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 25195501)

  • 1. Uhthoff's phenomenon in multiple sclerosis and neuromyelitis optica.
    Park K; Tanaka K; Tanaka M
    Eur Neurol; 2014; 72(3-4):153-6. PubMed ID: 25195501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Current symptomatology in multiple sclerosis and neuromyelitis optica.
    Muto M; Mori M; Sato Y; Uzawa A; Masuda S; Uchida T; Kuwabara S
    Eur J Neurol; 2015 Feb; 22(2):299-304. PubMed ID: 25264295
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modeling the mechanisms of Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
    Frohman TC; Davis SL; Frohman EM
    Ann N Y Acad Sci; 2011 Sep; 1233():313-9. PubMed ID: 21951010
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of visual acuity and automated perimetry findings in patients with neuromyelitis optica or multiple sclerosis after single or multiple attacks of optic neuritis.
    Fernandes DB; Ramos Rde I; Falcochio C; Apóstolos-Pereira S; Callegaro D; Monteiro ML
    J Neuroophthalmol; 2012 Jun; 32(2):102-6. PubMed ID: 22157535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Long-lasting and isolated Uhthoff's phenomenon after effort preceding multiple sclerosis].
    Fromont A; Bénatru I; Gignoux L; Couvreur G; Confavreux C; Moreau T
    Rev Neurol (Paris); 2010 Jan; 166(1):61-5. PubMed ID: 19473682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modeling Uhthoff's phenomenon in MS patients with internuclear ophthalmoparesis.
    Davis SL; Frohman TC; Crandall CG; Brown MJ; Mills DA; Kramer PD; Stüve O; Frohman EM
    Neurology; 2008 Mar; 70(13 Pt 2):1098-106. PubMed ID: 18287569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pain in neuromyelitis optica and its effect on quality of life: a cross-sectional study.
    Kanamori Y; Nakashima I; Takai Y; Nishiyama S; Kuroda H; Takahashi T; Kanaoka-Suzuki C; Misu T; Fujihara K; Itoyama Y
    Neurology; 2011 Aug; 77(7):652-8. PubMed ID: 21813781
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Neuromyelitis optica IgG and related clinical features of patients with neuromyelitis optica].
    You XF; Ye J; Li CJ; Liao ZY; Sun H
    Zhonghua Yi Xue Za Zhi; 2010 Sep; 90(35):2477-80. PubMed ID: 21092475
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The hot bath test among Malaysian multiple sclerosis patients.
    Tan CT
    Med J Malaysia; 1994 Mar; 49(1):68-73. PubMed ID: 8057994
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Depressive state and chronic fatigue in multiple sclerosis and neuromyelitis optica.
    Akaishi T; Nakashima I; Misu T; Fujihara K; Aoki M
    J Neuroimmunol; 2015 Jun; 283():70-3. PubMed ID: 26004160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of deep gray matter lesions on magnetic resonance imaging among adults with acute disseminated encephalomyelitis, multiple sclerosis, and neuromyelitis optica.
    Zhang L; Wu A; Zhang B; Chen S; Men X; Lin Y; Lu Z
    Mult Scler; 2014 Apr; 20(4):418-23. PubMed ID: 23886831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elevated fibrinogen levels in neuromyelitis optica is associated with severity of disease.
    Zhang Y; Zhang X; Liu D; Wang H; Pan S; Wang D; Chen X
    Neurol Sci; 2016 Nov; 37(11):1823-1829. PubMed ID: 27450097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Can Uhthoff's sign be applied to the study of visual evoked potentials in multiple sclerosis without ocular manifestation?].
    Delplace MP; Guillaumat J
    Rev Otoneuroophtalmol; 1983; 55(2):111-8. PubMed ID: 6612163
    [No Abstract]   [Full Text] [Related]  

  • 14. The impact of diagnostic criteria for neuromyelitis optica in patients with MS: a 10-year follow-up of the South Atlantic Project.
    Papais-Alvarenga RM; Vasconcelos CC; Alves-Leon SV; Batista E; Santos CM; Camargo SM; Godoy M; Lacativa MC; Lorenti M; Damasceno B; Damasceno A; Brum D; Barreira AA; Guimarães Rocha MS; Alvarenga H; Tilbery CP
    Mult Scler; 2014 Mar; 20(3):374-81. PubMed ID: 23970504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Laryngeal Uhthoff's phenomenon: a case report.
    Pringle CE; McEwan LM; Ebers GC
    Mult Scler; 1995 Nov; 1(3):163-4. PubMed ID: 9345447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uhthoff's symptom in optic neuritis: relationship to magnetic resonance imaging and development of multiple sclerosis.
    Scholl GB; Song HS; Wray SH
    Ann Neurol; 1991 Aug; 30(2):180-4. PubMed ID: 1654765
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the T cell receptor repertoire in the Japanese neuromyelitis optica: T cell activity is up-regulated compared to multiple sclerosis.
    Warabi Y; Yagi K; Hayashi H; Matsumoto Y
    J Neurol Sci; 2006 Nov; 249(2):145-52. PubMed ID: 16860825
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uhthoff's phenomenon as the initial symptom in neuromyelitis optica spectrum disorders: a case report.
    Liang H; Xus C; Xu J
    Hong Kong Med J; 2023 Jun; 29(3):259-261. PubMed ID: 37349141
    [No Abstract]   [Full Text] [Related]  

  • 19. Notable increased cerebrospinal fluid levels of soluble interleukin-6 receptors in neuromyelitis optica.
    Wang H; Wang K; Zhong X; Dai Y; Qiu W; Wu A; Hu X
    Neuroimmunomodulation; 2012; 19(5):304-8. PubMed ID: 22777162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uhthoff's phenomenon as the first manifestation of multiple sclerosis in an adult male.
    Santos-Bueso E; Viera-Peláez D; Asorey-García A; Porta-Etessam J; Vinuesa-Silva JM; García-Sánchez J
    J Fr Ophtalmol; 2016 May; 39(5):e123-4. PubMed ID: 26949115
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.